Two new research studies have received the necessary regulatory and ethics approval to proceed as part of an evaluation of puberty blockers for young trans people. The studies, known as Pathways Trial and Pathways Connect, will take place at King’s College London. They will involve around 220 people under the age of 16. These trials […]
From Canary via This RSS Feed.
You must log in or # to comment.